Roche/Amgen EPO Fight Gets Senate Hearing On Patent Defense Rules
Executive Summary
The Senate Judiciary Committee is looking at whether to revise an obscure provision in patent law that could affect litigation between Amgen and Roche
You may also be interested in...
Roche Wins Ruling On Mircera Importation; Court to Hear Injunction Appeal
Although it may not make much difference for its follow-on biologic Mircera (epoetin beta), Roche has won a battle with Amgen that could affirm a layer of intellectual property protection for all follow-on biologics in the U.S
Roche Wins Ruling On Mircera Importation; Court to Hear Injunction Appeal
Although it may not make much difference for its follow-on biologic Mircera (epoetin beta), Roche has won a battle with Amgen that could affirm a layer of intellectual property protection for all follow-on biologics in the U.S
Amended Patent Bill Limits Opportunities For “Second Window” Review
A new version of patent reform legislation would allow a patent to be challenged anytime during its life, but set stricter requirements for requesting a review after the first year